Woodline Partners’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.6M | Sell |
4,000,029
-1,127,275
| -22% | -$9.18M | 0.17% | 168 |
|
|
2025
Q1 | $40.2M | Buy |
5,127,304
+1,603,367
| +45% | +$12.6M | 0.26% | 116 |
|
|
2024
Q4 | $52.5M | Buy |
3,523,937
+45,497
| +1% | +$677K | 0.35% | 72 |
|
|
2024
Q3 | $53.2M | Sell |
3,478,440
-766,781
| -18% | -$11.7M | 0.45% | 57 |
|
|
2024
Q2 | $64.7M | Buy |
4,245,221
+1,361,564
| +47% | +$20.7M | 0.62% | 37 |
|
|
2024
Q1 | $54.4M | Buy |
2,883,657
+1,846,375
| +178% | +$34.9M | 0.5% | 52 |
|
|
2023
Q4 | $19.8M | Hold |
1,037,282
| – | – | 0.22% | 143 |
|
|
2023
Q3 | $18.6M | Buy |
1,037,282
+789,282
| +318% | +$14.2M | 0.22% | 141 |
|
|
2023
Q2 | $5.04M | Buy |
+248,000
| New | +$5.04M | 0.06% | 287 |
|
|
2023
Q1 | – | Sell |
-1,201,150
| Closed | -$24.8M | – | 757 |
|
|
2022
Q4 | $24.8M | Buy |
+1,201,150
| New | +$24.8M | 0.33% | 79 |
|
|
2022
Q2 | – | Sell |
-261,419
| Closed | -$8.25M | – | 871 |
|
|
2022
Q1 | $8.25M | Sell |
261,419
-1,445,006
| -85% | -$45.6M | 0.13% | 189 |
|
|
2021
Q4 | $69.1M | Buy |
1,706,425
+7,312
| +0.4% | +$296K | 0.99% | 14 |
|
|
2021
Q3 | $59.2M | Buy |
1,699,113
+35,545
| +2% | +$1.24M | 0.97% | 20 |
|
|
2021
Q2 | $45.7M | Buy |
1,663,568
+425,838
| +34% | +$11.7M | 0.85% | 23 |
|
|
2021
Q1 | $34.8M | Buy |
+1,237,730
| New | +$34.8M | 0.77% | 34 |
|
|
2020
Q2 | – | Sell |
-98,516
| Closed | -$1.37M | – | 180 |
|
|
2020
Q1 | $1.37M | Buy |
+98,516
| New | +$1.37M | 0.1% | 122 |
|